The Independent Voice of
European Private Equity

Advanced Search

Keensight Capital backs CatSci

Simon Thompson 15 June 2022

Drugs
  • Keensight will support continued growth of the core business via capability and site expansion, as well as the development of its capabilities.

Related Articles

Inflexion-backed Detectortesters expands in the US with new acquisition

17/05/24

Fund in Focus: Headway Capital renews emphasis on deal-by-deals through latest fund

17/05/24

Polaris picks up InArea Group minority stake

17/05/24

Argos Wityu acquires German bakery chain

17/05/24

Aksia sells Italian bakery portco to Wise Equity

17/05/24

Inflexion backs training and nutrition programme provider Ultimate Performance

17/05/24